Blog

The FDA's Advanced Manufacturing Initiative Is What We Do

There is great opportunity to leverage digital technologies that improve product quality and yield, process efficiency, on-time delivery and sustainability in pharma manufacturing.

White Paper

Solution Brief: Accelerate Market Growth with New Advances in Process Analytical Technology

Pharmaceutical companies, CDMOs and CMOs continue to grapple with the tension between meeting the demand for increasingly diverse pharmaceutical products and the escalating challenges in ensuring supply, especially during periods of disruption.

White Paper

Digitalization for Pharmaceuticals: Safeguarding Product Supply by Ensuring Asset and Process Health

In the pharmaceutical industry, equipment failures, changing operating conditions and other unexpected occurrences can cause batch failures, resulting in costly production losses and disruptions to supply. So how can companies maintain the security of supply while protecting profits?

Video

Optimizing Outcomes Across the Pharma Value Chain Network

AspenTech provides AI-enabled digital solutions that help customers optimize outcomes across the pharma value chain network using a holistic approach to digital transformation in an ever-changing world. Learn how our approach ensures the security of supply and pushes the boundaries and limits of what is possible for optimization, multiplying performance gains from digital transformation in this video.

Video

How Pharmaceutical Firms Can Use Data and AI with Confidence

Pharma and biotech companies face a pivotal next step in addressing the increased complexity of production while balancing mounting cost pressures with the need to ensure product quality, security of supply and regulatory compliance. Learn how Pharmaceutical and Biotech Companies can use Data and AI with confidence in this brief video about our research report.

Report

Culture Reimagined: How Pharmaceutical Firms Can Use Data and AI with Confidence

Pharma and biotech companies face a pivotal next step in addressing the increased complexity of production while balancing mounting cost pressures with the need to ensure product quality, security of supply and regulatory compliance. Findings from AspenTech® and Longitude’s recent market survey revealed that digital culture and technology adoption provide a competitive edge – but adoption is slow.

On Demand Webinar

How a Multinational Biopharma Used PAT to Shift From Batch to Continuous Manufacturing

Pharma companies continue to strive for tight control of critical quality attributes (CQAs). When Ferring Pharmaceuticals wanted to move from batch to continuous manufacturing, they found that laboratory assays were too time consuming to provide meaningful feedback for real-time control, and 100% product quality inspection was not possible.

On Demand Webinar

Optimizing Outcomes Across the Pharma Value Chain Network featuring Axendia

The ability of bio-pharmaceutical manufacturers to deliver quality drug products during challenging market conditions is critical for ensuring sustainability over the long run. The COVID-19 pandemic underscored the need to transform the traditional bio-pharmaceutical supply chain to have greater agility and resiliency during market swings and periods of volatility.

On Demand Webinar

Accelerate Market Growth with New Advances in Process Analytical Technology (PAT)

Pharmaceutical companies, CDMOs and CMOs face growing pressures to deliver more products at a lower cost while ensuring the quality and security of supply. Advanced PAT technologies address these challenges by increasing saleable product through more consistent quality, higher yields and greater throughput. In addition, digitalization advances such as extensive connectivity, increased and elastic computing power, and advanced analytics have all continued to strengthen the accessibility and power of PAT to accelerate market growth.

On Demand Webinar

How are Pharmaceutical and Biotech Companies Using Data and AI with Confidence?

Pharma and biotech companies face a pivotal next step in addressing the increased complexity of production while balancing mounting cost pressures with the need to ensure product quality, security of supply and regulatory compliance.

Page 1 of 3